IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,442 | -26.9% | 13,284 | +13.2% | 0.00% | -33.3% |
| Q2 2023 | $82,629 | +108622.4% | 11,737 | -6.5% | 0.00% | +50.0% |
| Q1 2023 | $76 | -62.2% | 12,550 | -60.2% | 0.00% | -75.0% |
| Q4 2022 | $201 | -100.0% | 31,539 | -43.9% | 0.01% | -11.1% |
| Q3 2022 | $539,000 | +91.8% | 56,267 | +120.8% | 0.01% | +50.0% |
| Q2 2022 | $281,000 | +485.4% | 25,484 | +787.3% | 0.01% | – |
| Q1 2022 | $48,000 | +700.0% | 2,872 | +715.9% | 0.00% | – |
| Q4 2021 | $6,000 | -64.7% | 352 | -46.2% | 0.00% | – |
| Q3 2021 | $17,000 | -81.5% | 654 | -81.4% | 0.00% | -100.0% |
| Q2 2021 | $92,000 | -96.7% | 3,519 | -96.0% | 0.00% | -95.7% |
| Q1 2021 | $2,765,000 | +68.4% | 87,355 | +146.9% | 0.05% | -6.0% |
| Q4 2020 | $1,642,000 | +1257.0% | 35,380 | +862.7% | 0.05% | +4900.0% |
| Q3 2020 | $121,000 | -80.6% | 3,675 | -83.9% | 0.00% | -96.2% |
| Q2 2020 | $625,000 | +7712.5% | 22,778 | +8006.0% | 0.03% | +2500.0% |
| Q4 2019 | $8,000 | -92.9% | 281 | -95.4% | 0.00% | -87.5% |
| Q3 2019 | $112,000 | +286.2% | 6,157 | +413.1% | 0.01% | +300.0% |
| Q2 2019 | $29,000 | -70.7% | 1,200 | -86.4% | 0.00% | -71.4% |
| Q3 2018 | $99,000 | +518.8% | 8,842 | +625.3% | 0.01% | +600.0% |
| Q2 2018 | $16,000 | +1500.0% | 1,219 | +2157.4% | 0.00% | – |
| Q1 2018 | $1,000 | -80.0% | 54 | -92.0% | 0.00% | -100.0% |
| Q4 2017 | $5,000 | -93.0% | 672 | -92.7% | 0.00% | -83.3% |
| Q3 2017 | $71,000 | +3450.0% | 9,190 | +3193.9% | 0.01% | – |
| Q2 2017 | $2,000 | – | 279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |